1.
Folia Med (Plovdiv)
; 66(2): 255-263, 2024 Apr 30.
Artículo
en Inglés
| MEDLINE
| ID: mdl-38690822
RESUMEN
INTRODUCTION: In the period between 1997 and 2010, sibutramine-containing drugs were widely prescribed for obesity and over-weight management. Due to safety concerns, in 2010 all medicines containing sibutramine were urgently withdrawn from the USA and European pharmaceutical market. Although sibutramine is no longer available in pharmaceutical products, there have been numerous reports of mislabeled weight-loss dietary supplements containing sibutramine.